City

Aktobe (1)

Copenhagen (1)

Overall Status

Completed (1)

Recruiting (1)

Phase

phase 2 (1)

Sponsor

Rigshospitalet, Denmark (1)

West Kazakhstan Medical University (1)

Collaborator

Groupe Hospitalier Pitie-Salpetriere (1)

Intervention

bezafibrate (1)

obtaining dry blood spots from healthy children aged 8 days - 7 years (1)

obtaining dry blood spots from healthy children aged 8-18 years (1)

obtaining dry blood spots from healthy newborns (aged 1-7 days) (1)

obtaining dry blood spots from high-risk childrens (aged 8 - 18 years) (1)

obtaining dry blood spots from high-risk childrens (aged 8 days- 7 years) (1)

obtaining dry blood spots from high-risk newborns (aged 1-7 days) (1)

placebo (1)

Study Documents

Intervention Type

diagnostic test (1)

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational [Patient Registry] (1)

carnitine palmitoyltransferase ii deficiency

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Propionic/Methylmalonic Acidemias, Maple Syrup Urine Disease, Citrullinemia Trial in Aktobe (Obtaining Dry Blood Spots From

Recruiting

Propionic/Methylmalonic Acidemias
+28 more

Obtaining Dry Blood Spots From Healthy Newborns (Aged 1-7 Days)
+5 more

Aktobe, Aktobe Region, Kazakhstan

Regional perinatal center of Aktobe region

Jun 8, 2023

Carnitine Palmitoyltransferase II Deficiency, Very Long Chain Acyl Coa Dehydrogenase Deficiency Trial in Copenhagen

Completed

Carnitine Palmitoyltransferase II Deficiency
Very Long Chain Acyl Coa Dehydrogenase Deficiency

Bezafibrate
Placebo

Copenhagen, Denmark

Neuromusculare Research Unit, Rigshospitalet

May 29, 2012